Release Date: 25/08/17 13:24 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 253.79KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%